Plus Therapeutics stock plunges after pricing $15M units offering
Source: SeekingAlpha
2026-01-14 08:12:55 ET
More on Plus Therapeutics
- Plus Therapeutics, Inc. (PSTV) Presents at 2025 San Antonio Breast Cancer Symposium (SABCS) - Slideshow
- Plus Therapeutics granted 180-day to regain compliance with Nasdaq
- Seeking Alpha’s Quant Rating on Plus Therapeutics
- Historical earnings data for Plus Therapeutics
- Financial information for Plus Therapeutics
Read the full article on Seeking Alpha
For further details see:
Plus Therapeutics stock plunges after pricing $15M units offering
PLUS THERAPEUTICS Inc.
NASDAQ: PSTV
PSTV Trading
0.21% G/L:
$0.2871 Last:
1,087,002 Volume:
$0.2822 Open:
PSTV Latest News
February 25, 2026 07:30:00 am
Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ(TM)
January 22, 2026 07:45:00 am
Plus Therapeutics Provides Business Update on REYOBIQ(TM) Clinical Program and U.S. CNSide® Commercialization
January 21, 2026 04:15:00 pm
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET
January 14, 2026 08:00:00 am
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
PSTV Stock Data
$37,787,078
135,702,904
0.32%
20
N/A
Biotechnology & Life Sciences
Healthcare
US
Houston
